SIR-Spheres: Completed Phase III enrollment

Sirtex said investigators completed enrollment of >=360 patients in the open-label, international Phase III SIRveNIB trial comparing a single dose of SIR-Spheres yttrium-90 microspheres vs. twice-dail...